scispace - formally typeset
Open AccessJournal ArticleDOI

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.

TLDR
The possible role of STAT3 signaling cascade and its interacting partners in the initiation of HCC is discussed and the role of various STAT3 regulated genes in HCC progression, inflammation, survival, invasion and angiogenesis is analyzed.
About
This article is published in Biochimica et Biophysica Acta.The article was published on 2013-01-01 and is currently open access. It has received 256 citations till now. The article focuses on the topics: STAT3 & STAT protein.

read more

Citations
More filters
Journal Article

The structure

Bill Welch
Journal ArticleDOI

The immunology of hepatocellular carcinoma.

TL;DR: The roles of specific immune cell subsets in chronic liver disease, with a focus on non-alcoholic steatohepatitis and HCC are summarized and the challenges posed by the immunotolerant hepatic environment are discussed.
Journal ArticleDOI

Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.

TL;DR: The evidence for critical roles ofSTAT3 in oncogenesis is presented and the potential for development of novel cancer therapies based on mechanistic understanding of STAT3 signaling cascade is discussed.
Journal ArticleDOI

Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

TL;DR: Examples of the functions of ncRNAs in liver cancer and their potential use for the detection and treatment of liver cancer are reviewed.
References
More filters
Journal ArticleDOI

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

TL;DR: The work from the authors' laboratories reviewed herein was supported by grants from the National Cancer Institute.
Journal ArticleDOI

Rho GTPases and the Actin Cytoskeleton

TL;DR: Members of the Rho family of small guanosine triphosphatases have emerged as key regulators of the actin cytoskeleton, and through their interaction with multiple target proteins, they ensure coordinated control of other cellular activities such as gene transcription and adhesion.
Journal ArticleDOI

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

TL;DR: A previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that phosphorylate substrate proteins called STATs (signal transducers and activators of transcription).
Journal ArticleDOI

The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

TL;DR: Small-molecule therapeutics that block PI3K signalling might deal a severe blow to cancer cells by blocking many aspects of the tumour-cell phenotype.
Journal ArticleDOI

What is the evidence that tumors are angiogenesis dependent

TL;DR: Method of treating a wound or burn which comprises directly dressing its surface with non-woven fabric comprising staple fibers of spun, regenerated collagen substantially free of telopeptides is disclosed.
Related Papers (5)
Frequently Asked Questions (21)
Q1. What is the main risk factor for the development of HCC?

Continuing hepatocyte death triggers compensatory repair and regeneration and eventually leads to severe fibrosis, the major clinical risk factor for the development of HCC [4,5,13]. 

Subramaniam et al. this paper showed that the potential role of signal transducer and activator of transcription ( STAT ) 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. 

A variety of animal models have been used to study the role of STAT3 signaling cascades in HCC development. Hence, the knowledge gained about STAT3 in HCC will depend on solutions to these potential problems. However, appropriate human studies are required to validate the promising results obtained in mice and move the STAT3 inhibitors from the bench side to the bed for the treatment of HCC patients. 

Sex hormones, such as estrogens, progesterone, and oral contraceptives have been shown to increase hepatic tumor development in animals. 

The JAKs in turn phosphorylate the specific tyrosines in the intracellular domain of gp130, providing docking sites for the Src homology 2 (SH2) domain of signaling molecules of STAT3. 

JAKs can either bind to intracellular domains of cytokine receptor signaling chains or catalyze ligand-induced phosphorylation of intracellular tyrosine residues on the receptor [140]. 

Activated STAT3 affects tumor angiogenesis by regulating the expression of multiple pro-angiogenic molecules in tumor cells and by participating in the signal transduction of angiogenic molecule receptors in tumor endothelial cells. 

When IL-6 binds to its specific receptor subunit, it can induce dimerization of gp130 receptor and activation of the gp130-associated JAK [52,139]. 

In addition to being associated with cell growth, STAT3 activation has been found to be critical for differentiation of keratinocytes [152], and myeloid cells [153], and plays an important role in mediating the formation of epithelial tubules in response to hepatocyte growth factor [154]. 

The amelioration of the malignant behaviors of HCCLM3 following orthotopic implantation, included impeded migration, hampered neovascularization, inhibited local metastasis, and reduced lung metastasis, indicating that STAT3 also mediates the metastatic potential of HCCLM3, a highly malignant variant of HCC [195]. 

The tetramerization of STATs contributes to stability of the STAT-DNA binding by means of the interaction with randomly arranged low-affinity STAT binding sites, thus increasing transcriptional activity [83]. 

STAT proteins have been shown to play pivotal roles in cytokine signaling pathways, which are involved in regulating cell growth and differentiation in systems ranging from Dictyostelium to mammals [38]. 

Recent studies have indicated that inappropriate expression of cell cycle-related proteins, such as cyclin D1, cyclin-dependent kinase 4 (Cdk4), cyclin E, cyclin A, p16 and p27, as one of the major factors contributing to HCC initiation and development [225–227]. 

In fact, loss of STAT3 is lethal even to embryonic stem cells [148] indicating a key role for STAT3 in cell growth and/or survival. 

Other physiological negative protein modulators of the STAT3 signaling pathway also involving negative regulation include the JAK binding protein (JAB) and STAT-induced STAT inhibitor [163]. 

In-vitro studies on keratinocytes have shown that STAT3 plays an important role in the migration of epidermal cells, and is essential for skin renovation [156]. 

The SH3 domain contributes to substrate recruitment [110,111] and is critical for the regulation of kinase activity [112–114], (Fig. 4). 

it is likely that STAT3 can act as a potential negative regulator of cyclinD1 transcription during fetal liver development, whereas it positively regulates cyclin D1 expression in hepatoma cells and at the initial phase of liver regeneration. 

While safety remains a point of concern, given the fact that STAT3-null mice are embryonically lethal, tissue-specific STAT3 deletion experiments have indicated that STAT3 may not be essential for the survival of normal differentiated cells. 

Targeting the SH2 domain would uncouple STAT3 from the growth and survival signaling pathways and is a reasonable approach for the development of anticancer agents [270,271]. 

The observed variation in the binding affinity of a particular activated STAT dimer for a single target DNA sequence is determined by differences in the nucleotide sequence [140].